{"version":"1.0","type":"link","title":"A Randomized Trial of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or FOLFIRI/Cetuximab in Chinese Patients With BRAF Mutant Metastatic Colorectal Cancer: The NAUTICAL Study.","author_name":"Xicheng W 외","author_url":"https://prs-insight.online/author/Xicheng%20W","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/104706","thumbnail_width":1200,"thumbnail_height":630}